Growing Market Presence Scene Health has secured $17.7 million in Series B funding in 2023, demonstrating strong investor confidence and expanding financial resources to support growth and technological advancements, making it an attractive partner for scaling healthcare solutions.

Innovative Technology Development The company is actively developing novel electronic adherence monitors in collaboration with partners like Impruvon Health, indicating a focus on cutting-edge digital health tools that enhance medication adherence and offer new product integration opportunities.

Expanding Customer Base With over 120 healthcare clients using their medication engagement programs, Scene Health presents a substantial client base in need of scalable solutions for chronic and infectious disease management, creating opportunities for upselling and new deployments.

Leadership & Strategic Focus Recent hiring of a Vice President of Population Health from UHC & Optum signals a strategic emphasis on population health management, opening avenues for partnerships in large-scale health initiatives and data-driven health interventions.

Market Expansion in Chronic Disease Launch of specific programs targeting hypertension and focus on patient-reported outcomes positions Scene Health to collaborate with payers, providers, and health systems seeking innovative approaches to improve medication adherence in key chronic conditions.